Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inter Parfums

This article was originally published in The Rose Sheet

Executive Summary

First quarter net sales jump 40% to $31 mil. excluding currency exchange, and net income advances 42.8% to $2 mil., due to continued rollout of Paul Smith and Burberry Touch fragrances and Christian Lacroix Eau Florale launch, says. Prestige sales led growth, while mass market sales were flat. New line of health and beauty aids shipping to mass retailers in second quarter expected to boost division sales in 2001, Inter Parfums says. SG&A expenses increased to 38% of sales in quarter to keep momentum going, firm says. Inter Parfums is projecting $28 mil. in second quarter revenues and expects 2001 sales to reach $115 mil

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009223

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel